Esther Yi, MS, PharmD

Pfizer
New York, New York, United States

Global Health Economics Outcomes Research, Market Access

0357: Content validation of patient-reported outcome (PRO) measures for fatigue, physical function and disease activity in Polymyositis (PM)

Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Pfizer: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
1889: Navigating Diagnostic Challenges: Insights into the Patient Journey and Delays in Diagnosing Dermatomyositis from a Real-world Survey in the United States and Europe

Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Pfizer: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)